Population Studies of Oral Diseases 
(Oral Epidemiology)

©The Maxillofacial Center for Diagnostics & Research


Other Links
Precancers
Cancer
References
Dr. Bouquot's Work
Home Page


This Topic
Benign Mucosal Lesions
Oral Precancers
Cancers
Tongue & Lip Lesions
Salivary & Bone Tumors

Age & Oral Lesions

Annual incidence of salivary tumors, Rochester, Minnesota, 1935-1984

The Maxillofacial Center, 165 Scott Avenue, Suite 100, Morgantown, WV 26508  MFCenter@aol.com


Prevalence of Benign Oral Mucosal & Soft Tissue Lesions
(Excludes Precancer Studies & Site-Specific Studies)
Listed by Size of Population Studied

Click on Author Name(s) to See Data Table

Author(s) *

Year Country Population Size Population Type
Knapp 1971 USA 181,338 Army recruits (young males)
Kleinman, et al. 1993 USA 39,206 School children (5-17 y/o)
Bouquot 1986 USA 23,616 Over 35 years of age
Bouquot (expanded) ** 2000 USA 23,616 Over 35 years of age
Axéll 1976 Sweden 20,233 Adults
Ross, Gross 1971 USA 11,884 Over 35 years of age
Zain, et al. 1997 Malaysia 11,707 Over 25 years of age

The following studies are on another web page of this site [click on author name(s)].

Diaz-Guzman, Castellanos 1991 Mexico 7,292 Adults (avg. age: 32 years)
Ikeda, et al. 1995 Cambodia 5,000 Adults
Zachariah 1966 India 5,000 Adults, rural
Prout, et al. 1997 USA 4,611 Tobacco users > 40 y/o
Baciero, et al 2000 Spain 3,282 Over 65 years of age
Fatahzaden, Keno, Sirois 2000 USA 1,125 Adults
Hand, Whitehall 1986 USA 976 Elderly (nursing home)
Guggenheimer, et al. 2000 USA 673 Adults; diabetics & controls

       * Complete references are above each data table
     ** Expanded listing of Dr. Bouquot's 1986-1988 data; previously unpublished data are included


 

Table 1 (Knapp): Prevalence rates (per 1,000 persons) for oral mucosal lesions found in clinical exams of 181,338 Army recruits, predominantly men 18-22 years of age.

Reference: Knapp MJ. Oral disease in 181,338 consecutive oral examinations. J Amer Dent Assoc 1971; 83:1288-1293.

Clinical Diagnosis

# Lesions

# Lesions/1,000 Persons

Papillary hyperplasia

1292

7.12

Papilloma

405

2.23

Irritation fibroma

216

1.19

Other, includes 49 different diagnoses

111

0.61

Inflammatory ulcer

87

0.48

Epulis fissuratum

67

0.37

Oral tonsils, hyperplastic (lingual & other)

48

0.26

Mucocele

44

0.24

Leukoplakia

37

0.20

Frictional keratosis (cheek bite)

34

0.19

Verruca vulgaris

22

0.12

Hemangioma

21

0.12

Pyogenic granuloma

15

0.08

Lichen planus

13

0.07

Dental fistula

13

0.07

Geographic tongue

12

0.07

Median rhomboid glossitis

12

0.07

Amalgam tattoo

10

0.06

Hairy tongue (black)

6

0.03

Erythema multiforme

6

0.03

Angular cheilitis

4

0.02

Smokeless tobacco keratosis

4

0.02

Nicotine palatinus

2

0.01

White sponge nevus

2

0.01

Candidiasis

2

0.01

Actinic cheilosis

1

0.01

Darier's disease

1

0.01

Mucoepidermoid carcinoma

1

0.01

 


Table 2 (Kleinman, et al): Prevalence rates (per 1,000 persons) for oral mucosal lesions found in clinical exams of 39,206 school children, ages 5-17 years.  This was part of the 1986/87 National Survey of Oral Health performed by NIH (NIDR).

Reference: Kleinman DV, Swango PA, Pindborg JJ. Epidemiology of oral mucosal lesions in United States schoolchildren: 1986-87. Community Dent Oral Epidemiol 1994; 22:243-253.

Clinical Diagnosis

# Lesions

# Lesions per
1,000 Persons

Estimated # U.S. Children Affected

Aphthous ulcer

524 12.3 533,588

Herpes labialis

323 7.8 337,869

Smokeless tobacco keratosis *

251 7.1 308,578

Geographic tongue

235 6.0 260,503

Other **

108 2.9 123,819

Tumors, non-specific ***

78 1.9 80,850

Unknown

48 1.1 48,999

Ulcers, non-specific

25

0.9 38,280

Mucocele

17 0.4 16,458

Acute necrotizing ulcerative gingivitis

10 0.3 13,413

Verruca vulgaris

12 0.3 12,057

Gingival hyperplasia

12 0.3 16,493

Primary herpetic gingivostomatitis

4 0.2 9,766

Candidiasis

1 0.1 315

   * Almost all cases were found in white males 12 years of age and older.
 
** Most of the "other" lesions were chronic cheek bit and lip bite, unspecified pigmented macules and dental               abscesses.
*** Tumors were usually firm and of normal color, i.e. were probably mostly irritation fibromas


 

Table 3 (Bouquot): Prevalence rates (per 1,000 persons) for visible oral lesions found in 23,616 adults (predominantly whites) over 35 years of age who attended well publicized oral cancer screening clinics in 13 communities in Minnesota, USA.  The represents approximately 2/3 of all older adults in the smaller communities (11 of the 13 communities studies).

Reference: Bouquot JE. Common oral lesions found during a mass screening examination. J Amer Dent Assoc 112:50-57, 1986.

Clinical Diagnosis

# lesions/1,000 persons

Males

Females

Total

Leukoplakia

43.2

20.9

28.9

Lesion, NOS, oral

23.5

17.6

19.7

Torus palatinus

13.2

21.7

18.7

Irritation fibroma

13.0

11.4

12.0

Fordyce granules

17.7

5.2

9.7

Torus mandibularis

9.6

7.9

8.5

Lesion, NOS, other

3.5

6.9

5.7

Hemangioma, oral

8.4

4.1

5.6

Inflammatory ulcer

5.4

5.1

5.2

Inflammatory erythema, oral

4.5

4.8

4.7

Papilloma

5.3

4.2

4.6

Epulis fissuratum

3.5

4.4

4.1

Varicosities, lingual

3.5

3.4

3.5

Fissured tongue

3.5

3.1

3.3

Inflammatory erythema, oropharynx

3.5

3.0

3.2

Geographic tongue

3.4

3.0

3.1

Trauma, NOS (not otherwise specified), oral

2.9

3.2

3.1

Papillary hyperplasia

1.7

3.8

3.0

Herpes labialis

2.4

2.6

2.5

Mucocele

1.9

2.6

2.4

Scar tissue

2.4

1.9

2.1

Angular cheilitis

1.8

1.9

1.9

Smokeless tobacco keratosis

4.2

0.2

1.7

Hyperplastic lingual tonsil

2.4

1.2

1.6

Hematoma/echhymosis

1.9

1.3

1.5

Frictional keratosis (cheek bite)

0.7

1.4

1.1

Hyperplastic pharyngeal tonsil

1.5

0.9

1.1

Lichen planus

1.2

1.1

1.1

Squamous cell carcinoma

2.5

0.1

0.9

Severe epithelial dysplasia

2.1

0.3

0.9

Buccal exostosis

0.9

0.9

0.9

Leaf-shaped fibroma (beneath denture)

0.4

1.2

0.9

Amalgam tattoo

0.6

1.0

0.8

Median rhomboid glossitis

0.8

0.5

0.6

Hairy tongue (black)

1.2

0.3

0.6

Glossitis, atrophic

0.6

0.5

0.6

Nicotine palatinus

1.2

0.2

0.6

Epidermoid cyst

0.7

0.4

0.5

Nevocellular nevus, oral

0.1

0.7

0.5

Oral melanotic macule

0.5

0.3

0.4

Non-lingual oral tonsils, hyperplastic

0.5

0.3

0.4

Leukoedema

0.4

0.3

0.3

Herpes zoster, intraoral

0.5

0.2

0.3

Lipoma

0.1

0.4

0.3

Pseudomembranous candidiasis

0.4

0.2

0.3

Herpes simplex, intraoral

0.1

0.3

0.2

Ranula

0.2

0.1

0.2

Sialolithiasis

0.0

0.3

0.2

Bifid uvula

0.4

0.0

0.1

White coated tongue

0.4

0.0

0.1

Gingival hyperplasia

0.1

0.1

0.1

Hyperplastic buccinator node

0.1

0.1

0.1

Commissural lip pits

0.1

0.1

0.1

Cyst of Blandin-Nuhn

0.0

0.1

0.1

Basal cell carcinoma, vermillion

0.1

0.0

0.0

Macroglossia

0.0

0.1

0.0

Pyogenic granuloma

0.0

0.1

0.0

Nasoalveolar cyst

0.0

0.1

0.0

Neurofibroma

0.0

0.1

0.0

 


 

Table 4 (Bouquot, Extended): Gender-specific prevalence rates for all mucosal, soft tissue and bony oral and oropharyngeal lesions clinically diagnosed in 23,616 white U.S. adults (97% whites; 8,477 males, 15,139 females) over 35 years of age, ranked by total prevalence. 

References: Modified and extended from Bouquot's earlier published papers.

Clinical Diagnosis

    # Lesions/1,000 persons

Male

Female

Total

Leukoplakia 42.47 13.14 23.67
Lesion, NOS, oral 23.48 17.64 19.73
Torus palatinus 13.21 21.73 18.67
Irritation fibroma 12.98 11.36 11.94
Fordyce granules 17.69 5.15 9.65
Torus mandibularis 9.56 7.86 8.47
Lesion, NOS, other 3.54 6.94 5.72
Hemangioma, oral 8.38 4.10 5.63
Inflammatory ulcer 5.43 5.09 5.21
Inflammatory erythema, oral 4.48 4.76 4.66
Papilloma 5.31 4.16 4.57
Epulis fissuratum 3.42 4.36 4.02
Varicosities 3.54 3.43 3.47
Fissured tongue 3.54 3.10 3.26
Inflammatory erythema, oropharynx 3.54 2.97 3.18
Geographic tongue 3.42 2.97 3.13
Trauma, NOS, oral 2.95 3.24 3.13
Papillary hyperplasia 1.65 3.77 3.01
Herpes labialis 2.36 2.64 2.54
Mucocele 1.89 2.64 2.37
Scar tissue 2.36 1.92 2.07
Angular cheilitis 1.77 1.85 1.82
Hyperplastic lingual tonsil 2.36 1.19 1.61
Hematoma/echhymosis 2.01 1.39 1.61
Frictional keratosis (cheek bite) 0.71 1.39 1.14
Hyperplastic pharyngeal tonsil 1.53 0.86 1.10
Lichen planus 1.18 1.06 1.10
Smokeless tobacco keratosis 2.71 0.07 1.02
Buccal exostosis 0.94 0.86 0.89
Leaf-shaped fibroma (beneath denture) 0.35 1.19 0.89
Amalgam tattoo 0.59 0.99 0.85
Median rhomboid glossitis 0.83 0.53 0.64
Hairy tongue (black) 1.18 0.26 0.59
Glossitis, atrophic 0.59 0.53 0.55
Epidermoid cyst 0.71 0.40 0.51
Nevocellular nevus, oral 0.12 0.66 0.47
Leukoedema 0.83 0.13 0.38
Oral melanotic macule 0.47 0.33 0.38
Non-lingual oral tonsils, hyperplastic 0.47 0.33 0.38
Nicotine palatinus 0.59 0.13 0.30
Herpes zoster, intraoral 0.47 0.20 0.30
Lipoma 0.12 0.40 0.30
Pseudomembranous candidiasis 0.35 0.20 0.25
Ranula 0.12 0.33 0.25
Herpes simplex, intraoral 0.12 0.26 0.21
Sialolithiasis 0.00 0.26 0.17
Bifid uvula 0.35 0.00 0.13
White coated tongue 0.35 0.00 0.13
Gingival hyperplasia 0.12 0.13 0.13
Hyperplastic buccinator node 0.12 0.07 0.08
Commissural lip pits 0.12 0.07 0.08
Cyst of Blandin-Nuhn 0.00 0.13 0.08
Basal cell carcinoma, vermilion 0.12 0.00 0.04
Macroglossia 0.00 0.07 0.04
Pyogenic granuloma 0.00 0.07 0.04
Nasoalveolar cyst 0.00 0.07 0.04
Neurofibroma 0.00 0.07 0.00

Diagnoses of biopsied oral leukoplakias:

Hyperkeratosis without dysplasia 9.67 3.30 5.59
Severe epithelial dysplasia 2.36 0.33 1.06
Squamous cell carcinoma I 2.71 0.07 1.02
Clinical Diagnosis, Face/Neck Lesions:
Lesion, NOS, face/neck * 11.09 9.78 10.25
Nevocellular nevus, face/neck 5.66 6.61 6.27
Actinic keratosis, face/neck 3.66 4.03 3.90
Cervical adenopathy, inflammatory 3.07 4.03 3.68
Enlarged thyroid gland 0.47 3.17 2.20
Basal cell carcinoma, face 3.19 1.65 2.20
Seborrheic keratosis, face/neck 1.53 1.39 1.44
Lipoma, face/neck 1.42 0.99 1.14
Sebaceous cyst, face/neck 1.65 0.79 1.10
Verruca vulgaris, face/neck 1.30 0.46 0.76
Hemangioma, face 0.59 0.33 0.42
Xanthoma/xanthelasma, face 0.24 0.20 0.21
Osteoma, facial bones/skull 0.12 0.13 0.13
Thyroglossal duct cyst, neck 0.24 0.00 0.08
Nasal polyp 0.12 0.00 0.04
Malignant melanoma, face

0.00

0.07 0.04
Butterfly rash of lupus 0.00 0.07 0.04
History of Oral Cancer:
No lesion, history of oral cancer 2.40 0.73 1.31
No lesion, family history of oral cancer 3.64 2.51 2.89
Oral carcinoma, history of previous oral cancer 0.51 0.00 0.18
Oral leukoplakia, history of previous oral carcinoma 1.37 0.18 0.59

* NOS = not otherwise specified; all cases biopsy proven and included in leukoplakia rates, except the single case of basal cell carcinoma of the vermilion border


 

Table 5 (Axéll): Prevalence rates (per 1,000 persons) of visible oral lesions among 8,696 Swedish adults attending special oral examination clinics.

Reference: Axell T. A preliminary report on prevalences of oral mucosal lesions in a Swedish population. Community Dent Oral Epidemiol 1975;3:143-145. Axell, T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odont Revy 1976; 27 (suppl 26):1-103.

Clinical Diagnosis

#
Lesions

# Lesions/
1,000 Persons

Fordyce granules

6,783

780.0

Leukoedema

3,994

459.3

History of aphthous ulcers

1,636

188.1

Inflammatory erythema, oral ("denture sore mouth")

1,127

129.6

History of herpes labialis

1,096

126.0

Oral melanotic macule ("excessive pigmentation")

873

100.4

Amalgam tattoo

713

82.0

Flabby ridge

624

71.8

Geographic tongue

624

71.8

Smokeless tobacco keratosis ("snuff dipper's lesion")

537

61.8

Fissured tongue

484

55.7

Preleukoplakia

472

54.3

Frictional keratosis ("cheek & lip biting")

411

47.3

Herpes labialis

279

32.1

Leukoplakia

272

31.3

Angular cheilitis

247

28.4

Epulis fissuratum (denture hyperplasia)

237

27.3

Irritation fibroma & fibroepithelial polyp

180

20.7

Traumatic ulcer

155

17.8

Smooth red tongue (atrophic glossitis)

152

17.5

Lichen planus

142

16.3

Nicotine palatinus

38

4.4

Hairy tongue

30

3.4

Glossitis, NOS

11

1.3

Papilloma

5

0.6

Lipoma

5

0.6

Pseudomembranous candidiasis, acute

4

0.5

Gingival hyperplasia, Dilantin-related

3

0.3

Focal epithelial hyperplasia

3

0.3

Aphthous ulcers, major ("PMNR")

2

0.2

Lymphangioma

2

0.2

Hemangioma

2

0.2

Squamous cell carcinoma

1

0.1